|
US4076823A
(en)
*
|
1977-08-18 |
1978-02-28 |
E. R. Squibb & Sons, Inc. |
Triazolo-2,4-benzodiazepines
|
|
ES2139595T3
(es)
*
|
1991-04-23 |
2000-02-16 |
Toray Industries |
Derivados triazolicos triciclicos, fabricacion de los mismos y su utilizacion.
|
|
US5683998A
(en)
*
|
1991-04-23 |
1997-11-04 |
Toray Industries, Inc. |
Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
|
|
FR2769309B1
(fr)
|
1997-10-08 |
2001-06-15 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques comprenant un derive d'aminoacide en tant que base d'oxydation et nouveaux derives d'aminoacides
|
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
JP5127096B2
(ja)
|
1999-04-30 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用
|
|
US7144880B2
(en)
|
1999-04-30 |
2006-12-05 |
Regents Of The University Of Michigan |
Compositions relating to novel compounds and targets thereof
|
|
US7276348B2
(en)
*
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20030119029A1
(en)
*
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
JP2008528448A
(ja)
*
|
2005-01-03 |
2008-07-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
新規化合物に関連する組成物および方法、ならびにその標的
|
|
JP2008545757A
(ja)
|
2005-06-01 |
2008-12-18 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
溶媒和されていないベンゾジアゼピン組成物および方法
|
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
EP1948191B1
(de)
|
2005-11-01 |
2013-01-16 |
The Regents of the University of Michigan |
Neuartige 1,4-benzodiazepin-2,5-dione mit therapeutischen eigenschaften
|
|
DE102005061840A1
(de)
|
2005-12-23 |
2007-06-28 |
Merck Patent Gmbh |
Triazolderivate
|
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
EP2418206A3
(de)
|
2006-06-09 |
2012-06-27 |
The Regents of the University of Michigan |
Benzodiazepin-derivate zur behandlung von autoimmunerkrankungen
|
|
KR101164718B1
(ko)
|
2007-03-09 |
2012-07-11 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
신규 화합물 및 이의 표적에 관한 조성물 및 방법
|
|
MX2010002732A
(es)
|
2007-09-14 |
2010-06-02 |
Univ Michigan |
Inhibidores de f1f0-atpasa y metodos relacionados.
|
|
CN101918375A
(zh)
|
2007-11-06 |
2010-12-15 |
密歇根大学董事会 |
在皮肤病症的治疗中有用的苯并二氮杂*酮化合物
|
|
US8497307B2
(en)
|
2008-09-11 |
2013-07-30 |
The Regents Of The University Of Michigan |
Aryl guanidine F1F0-ATPase inhibitors and related methods
|
|
WO2010121164A2
(en)
|
2009-04-17 |
2010-10-21 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
|
EP2470020A4
(de)
|
2009-09-18 |
2013-03-13 |
Univ Michigan |
Benzodiazepinonverbindungen und behandlungsverfahren damit
|
|
WO2011062765A2
(en)
|
2009-11-17 |
2011-05-26 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
JP5856064B2
(ja)
|
2009-11-17 |
2016-02-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療特性を有する1,4−ベンゾジアゼピン−2,5−ジオンおよび関連化合物
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9422292B2
(en)
|
2011-05-04 |
2016-08-23 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2012174487A2
(en)
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
PL3157928T3
(pl)
|
2014-06-20 |
2019-07-31 |
Constellation Pharmaceuticals, Inc. |
Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
|